Deliver a professional meningococcal b protection service through Scripter's structured consultation pathway. Supply: MenB vaccines (Bexsero, Trumenba).

Book a demo Browse all PGDs

Illustration: Meningococcal B protection

What is Meningococcal B?

MenB vaccines (Bexsero, Trumenba) protect against group B meningococcus, the group behind most UK invasive disease. Multi-dose schedules differ by brand and age, which the pathway sequences correctly.

The condition it treats

Group B meningococcal disease strikes fast and young: infants, teenagers and young adults in shared accommodation carry the highest risk. Private vaccination fills the gaps the routine programme leaves, including older children and university entrants.

How the service runs on Scripter

Patients book online, complete the pre-consultation questionnaire, and the guided pathway walks the practitioner through the meningococcal b protection consultation with the screening and counselling steps built in. The supply decision, the record and any GP notification are produced in the same flow, documented against the exact protocol version in force.

Training and eligibility requirements.

Who can deliver this service, and who it can be delivered to. The governing PGD document defines the definitive inclusion, exclusion and supply criteria; the Scripter consultation pathway enforces them, and every consultation is documented against the protocol version it ran under.

Practitioner training

✓Registered healthcare professional from a profession authorised to supply under PGDs (Schedule 16, Part 4 of the Human Medicines Regulations 2012), such as a pharmacist, nurse, paramedic or physiotherapist, with current registration with their professional regulator

✓Practising from premises suitable for the service, such as registered pharmacy premises or a registered clinic

✓Assessed clinical competency for this service, declared and reviewed as part of PGD authorisation

✓Sign-off against the current version of this PGD in Scripter before first supply; sign-offs expire automatically when the protocol is updated, and the platform notifies everyone affected

✓In-date basic life support and safeguarding training

✓Indemnity arrangements covering the service

✓Face-to-face injection technique training for the relevant route

✓In-date anaphylaxis recognition and management training, with adrenaline available on site

✓Vaccine storage and cold-chain procedures in place where the service supplies vaccines

Patient eligibility

✓Patients requesting MenB protection who fall within the governing PGD's age and risk criteria

✓Brand and schedule chosen per age group; multi-dose course booked to completion

✓Standard vaccine screening completed

✓Paracetamol advice for infants counselled where applicable (fever after Bexsero is common)

Meningococcal B PGD questions

My teenager had MenACWY at school; is B covered?+

No; the school dose covers A, C, W and Y. Group B needs its own course, which is the commonest reason families come through this pathway.

How many doses will be needed?+

It depends on brand and age at first dose; the consultation lays out the exact schedule and the booking flow holds the follow-ups.

Why the paracetamol advice for babies?+

Bexsero commonly causes fever in infants and prophylactic paracetamol is formally recommended alongside it; the counselling step scripts the doses for parents.

More travel health PGDs.

Related protocols in the same category, all delivered through the same platform.

Run a meningococcal b protection service without the paperwork.

See the consultation pathway, the sign-off tracking and the record it produces in a free 30-minute demo.

Book a demo Contact us

Built for pharmacists, by pharmacists.